甲状腺肿瘤SPECT-CT融合显像的应用近况

咸雨蔚; 左书耀

咸雨蔚 , 左书耀

文章导航 > 国际放射医学核医学杂志 > 2006, 30 > 3: (157-160)

引用本文:

Citation:

甲状腺肿瘤SPECT-CT融合显像的应用近况

266003 青岛, 青岛大学医学院附属医院核医学科
中图分类号: R814.4

Fusion images of SPECT-CT in the application of thyroid neoplasms

Department of Nuclear Medicine, Affiliated Hospital of Qingdao University, Qingdao 266003, China
CLC number: R814.4

摘要: 甲状腺肿瘤SPECT-CT融合显像将解剖成像与功能成像的优势相结合,克服了以往SPECT、CT单一成像的各自缺陷,可同时提供病变的解剖结构与功能代谢信息,能在术前对甲状腺肿瘤进行精确定位,在鉴别肿瘤良恶性、探测复发或转移、评价治疗效果等方面具有独特优势。与PET-CT相比,其价格低廉,具有较高的临床应用价值。
- 甲状腺肿瘤 /
- 体层摄影术,发射型计算机,单光子 /
- 体层摄影术,X线计算机 /
- 图像融合
Abstract: Fusion image of SPECT and CT on thyroid neoplasms has converged ascendancy of anatomic and functional image, overcome the inherent limitations of conventional single image modalities,and could provide good anatomic and functional data. It has distinct ascendancy in precise localization and qualitation of neoplasms presurgically, in monitoring the response to treatment and for detection recurrence or metastases. Moreover, it is cheap when compared with PET-CT, and can be of great value in clinical application.
- Thyroid neoplasms /
- Tomography,emission-computed,single-photon /
- Tomography,X-ray computed /
- Image fusion
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Rubello D, Piotto A, Pagetta C, et al. (99m)Tc-MIBI radio-guided surgery for recurrent thyroid carcinoma:technical-and preliminary clinical results. Eur J Nucl Med Mol Imaging, 2002, 29(9):1201-1205.
[2]	Forssel-Aronsson, Nilsson O, Benjegard SA, et al.¹¹¹In-DTPA-D-Phel-octreotide binding and somatostatin receptor subtype in thyroid tumour. J Nucl Med, 2000, 41(4):636-642.
[3]	Chang CT, Liu FY, Tsai JJ, et al. The clinical usefulness of dual phase ²⁰¹TI thyroid scan for false-negative fine-needle aspiration cytological diagnoses in non-functioning cold thyroid nodules.Anticancer Res, 2003, 23(3C):2965-2967.
[4]	Mitchell G, Pratt BE, Vini L, et al. False positive ¹³¹I whole body scans in thyroid cancer. Br J Radiol, 2000, 73(870):627-635.
[5]	Xie BK, Guan YB, Yuan XP, et al. Relationship between computed tomography(CT)manifestations and pathology in thyroid carcinoma. Ai Zheng, 2003, 22(2):192-197.
[6]	Schillaci O. Functional-anatomical image fusion in neuroendocrine tumours. Cancer Biother Radiopharm, 2004, 19(1):129-134.
[7]	Fujita A, Hyodog H, Kawamura Y, et al. Use of fusion images of I-131 metaiodobenzylguanidine, SPECT and magnetic resonance studies to identify a malignant phecchromocytoma. Clin Nucl Med,2000, 25(6):440-442.
[8]	Krausz Y, Keidar Z, Kogan I, et al. SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours. Clin Endocrinol (Oxf), 2003, 59(5):565-573.
[9]	Even-Sapir E, Keidar Z, Sachs J, et al. The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms. J Nucl Med, 2001, 42(7):998-1004.
[10]	Tharp K, Israel O, Hausmann J, et al. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging,2004, 31(10):1435-1442.
[11]	Kostakoglu L, Goldsmith SJ. ¹⁸F-FDG evaluation of the response to therapy for lymphoma and for breast,lung, and colorectal carcinoma. J Nucl Med, 2003, 44(2):224-239.
[12]	Chapman JD, Bradley JD, Eary JF, et al. Molecular (functional)imaging for radiotherapy applications:An RTOG symposium. Int J Radiat Oncol Biol Phys, 2003, 55(2):294-301.
[13]	Ruf J, Lelunkuhl L, Bertram H, et al. Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma. Nucl Med Commun, 2004, 25(12):1177-1182.
[14]	LUO Quan-yong, CHEN Li-bo, YU Yong-li, et al. Clinical analysis of false positive¹³¹I therapeutic scan in differentiated thyroid cancer. Chin J Med Imaging Technol. 2004, 20(12):1930-1932.
[15]	Akoglu E, Dutipek M, Bekis R, et al. Assessment of cervical lymph node metastasis with different imaging methods in patients with head and neck squamous cell carcinoma. J Otolaryngol, 2005, 34(6):384-394.
[16]	Yamamoto Y, Nishiyama Y, Monden T, et al. Clinical usefulness of fusion of ¹³¹I SPECT and CT images in patients with differentiated thyroid carcinoma. J Nucl Med, 2003, 44(12):1905-1910.
[17]	Schillaci O. Hybrid SPECT/CT:a new era for SPECT imaging?. Eur J Nucl Med Mol Imaging, 2005, 32(5):521-524.

[1]	查金顺 . SPECT-CT——核医学影像技术的新阶段. 国际放射医学核医学杂志, 2007, 31(3): 135-138.
[2]	汪太松 , 赵晋华 , 宋建华 . PET-MRI和多模式肿瘤显像. 国际放射医学核医学杂志, 2011, 35(5): 261-264. doi: 10.3760/cma.j.issn.1673-4114.2011.05.002
[3]	张弘 , 蒋宁一 . 图像融合在肿瘤中的应用. 国际放射医学核医学杂志, 2003, 27(1): 14-16,20.
[4]	梁琰 , 杜娟 , 李展展 , 张永强 , 王昀璐 , 赵杰 . ¹⁸F-FDG SPECT/CT显像与64排螺旋CT异机融合技术在胃癌诊断中的应用. 国际放射医学核医学杂志, 2017, 41(6): 385-388. doi: 10.3760/cma.j.issn.1673-4114.2017.06.002
[5]	李崇国 , 吴大可 , 郎锦义 . 基于非均匀有理B样条的四维心脏-躯干体模及其在医学影像研究中的应用. 国际放射医学核医学杂志, 2008, 32(6): 367-371.
[6]	冯学民 . 甲状腺癌的影像学研究进展. 国际放射医学核医学杂志, 2006, 30(5): 275-280.
[7]	程艳 , 王斌全 , 李思进 , 皇甫辉 , 刘涛 , 柴向斌 . SPECT-CT探测喉癌前哨淋巴结. 国际放射医学核医学杂志, 2008, 32(5): 268-271.
[8]	潘懿范 , 宋少莉 , 黄钢 . 比较SPECT-CT和PET-CT在小动物模型中的应用. 国际放射医学核医学杂志, 2009, 33(4): 196-199. doi: 10.3760/cma.j.issn.1673-4114.2009.04.002
[9]	陈贵兵 , 欧阳忠 , 韩成坤 , 黄劲雄 , 何小江 , 王凡 , 贾兵 , 吴华 . ⁹⁹Tc^m-3PRGD2整合素受体显像在乳腺癌定性诊断中的价值及与钼靶检查的对比研究. 国际放射医学核医学杂志, 2017, 41(1): 1-7. doi: 10.3760/cma.j.issn.1673-4114.2017.01.001
[10]	杨珂 , 唐波 , 于夕荣 , 张巍 . 甲状腺癌¹³¹I治疗病房的辐射屏蔽计算与评价. 国际放射医学核医学杂志, 2015, 39(5): 405-406, 419. doi: 10.3760/cma.j.issn.1673-4114.2015.05.012

点击查看大图

计量

文章访问数: 1371
HTML全文浏览量: 129
PDF下载量: 6

甲状腺肿瘤SPECT-CT融合显像的应用近况

266003 青岛, 青岛大学医学院附属医院核医学科

收稿日期: 2005-08-22

关键词:

摘要: 甲状腺肿瘤SPECT-CT融合显像将解剖成像与功能成像的优势相结合,克服了以往SPECT、CT单一成像的各自缺陷,可同时提供病变的解剖结构与功能代谢信息,能在术前对甲状腺肿瘤进行精确定位,在鉴别肿瘤良恶性、探测复发或转移、评价治疗效果等方面具有独特优势。与PET-CT相比,其价格低廉,具有较高的临床应用价值。